Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05355415 · ClinicalTrials.gov registry record
Adaptive Optics Imaging of Outer Retinal Diseases
A clinical trial of Age-related Macular Degeneration and Retinitis Pigmentosa, sponsored by Food and Drug Administration (FDA).
- Recruiting
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT05355415 is a study of Age-related Macular Degeneration and Retinitis Pigmentosa that is actively recruiting participants, run by Food and Drug Administration (FDA). The registered enrollment target is 100 participants, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05355415, a study of Age-related Macular Degeneration and Retinitis Pigmentosa, is actively recruiting participants, sponsored by Food and Drug Administration (FDA).
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.
Conditions Studied
Interventions
- DEVICE Adaptive optics imaging
Study Locations (2)
Maryland
- NIH Clinical Center - Bethesda
- Food and Drug Administration - Silver Spring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2026-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05355415
The ClinicalTrials.gov registry entry for NCT05355415 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (93% lower). The listed sponsor is Food and Drug Administration (FDA), which has 23 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which Adaptive optics imaging is the first listed.
NCT05355415 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05355415 about?
NCT05355415 is a clinical study titled "Adaptive Optics Imaging of Outer Retinal Diseases". The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomark...
What is the current status of trial NCT05355415?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-08-27. Estimated completion is 2026-08-27.
What conditions does trial NCT05355415 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Retinitis Pigmentosa, Retinal Degeneration, Cone-Rod Dystrophy, Cone Dystrophy.
What interventions are being tested in trial NCT05355415?
The interventions under investigation include: Adaptive optics imaging (DEVICE).
Who is sponsoring clinical trial NCT05355415?
This trial is sponsored by Food and Drug Administration (FDA), which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05355415 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.